Thus, the above data suggested that Tim-3 expression on Treg cells in the TME was STAT3-dependent, providing further support for STAT3 as a target and enhancing the immunotherapy for patients suffering from melanoma. The gene discussed is HAVCR2; the disease is melanoma.